HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis

Study Identifier
P15-665
CT.gov Identifier
NCT02916017
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Uveitis (UV)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    0 - 100 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Participants receiving adalimumab for the treatment of Non-infectious Intermediate-, Posterior-, or Pan-uveitis
    Exclusion Criteria:
    * Participants previously treated with adalimumab

    Protocol Summary

    This study evaluates the long- term safety and effectiveness of adalimumab in participants with non-infectious intermediate-, posterior-, or pan-uveitis in daily practice in Japan.

    Study Locations

    Location
    Status
    Location
    Juntendo University Urayasu Hospital /ID# 168358
    Urayasu-shi, Chiba, Japan, 279-0021
    Status
    Not applicable
    Location
    Matsuyama Red Cross Hospital /ID# 164149
    Matsuyama, Ehime, Japan, 790-0826
    Status
    Not applicable
    Location
    Kyushu University Hospital /ID# 163042
    Fukuoka, Fukuoka, Japan, 812-8582
    Status
    Not applicable
    Location
    Fukuoka University Hospital /ID# 163043
    Fukuoka, Fukuoka, Japan, 814-0180
    Status
    Not applicable
    Location
    Kurume University Hospital /ID# 162945
    Kurume-shi, Fukuoka, Japan, 830-0011
    Status
    Not applicable
    Location
    Gunma University Hospital /ID# 166916
    Maebashi, Gunma, Japan, 371-8511
    Status
    Not applicable
    Showing {first} - {last} of {total} Results